Glydo 2 % Topical Jelly

RxCUI: 1549447
RxNorm name: Glydo 2 % Topical Jelly
Display name: Glydo 2 % Topical Jelly
Full name: Glydo 2 % Topical Jelly
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
glydo	LIDOCAINE HYDROCHLORIDE	Sagent Pharmaceuticals	65760723-75cd-472c-96e1-7d05f95b4686	2026-02-04	Warnings, Adverse reactions	Exact identifier rxcui: 1549447

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
65760723-75cd-472c-96e1-7d05f95b4686	Glydo 2 % Topical Jelly [PSN] · lidocaine hydrochloride 0.02 MG/MG Topical Gel [Glydo] [SBD] · Glydo 2 % Topical Gel [SY]	3	12	These highlights do not include all the information needed to use GLYDO (lidocaine HCl jelly) 2% safely and effectively. See full prescribing information for GLYDO (lidocaine HCl jelly) 2%. GLYDO (lidocaine hydrochloride) 2% jelly Initial U.S. Approval: 1953	20260204